These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 570205

  • 1. Inhibition of complement-mediated lysis of sheep erythrocytes by cell-free preparations from Streptococcus mutans BHT.
    Silvestri LJ, Knox KW, Wicken AJ, Hoffmann EM.
    J Immunol; 1979 Jan; 122(1):54-60. PubMed ID: 570205
    [Abstract] [Full Text] [Related]

  • 2. Evidence for restriction of the ability of complement to lyse homologous erythrocytes.
    Houle JJ, Hoffmann EM.
    J Immunol; 1984 Sep; 133(3):1444-52. PubMed ID: 6430999
    [Abstract] [Full Text] [Related]

  • 3. Identification of RNA as a complement inhibitory component in an extract of Ehrlich ascites tumor cells.
    Renk CM, Hoffmann EM.
    J Immunol; 1977 Jul; 119(1):263-70. PubMed ID: 326959
    [Abstract] [Full Text] [Related]

  • 4. Serological properties of cellular and extracellular glycerol teichoic acid antigens of Streptococcus mutans.
    Hamada S, Mizuno J, Kotani S.
    Microbios; 1979 Jul; 25(101-102):155-66. PubMed ID: 120923
    [Abstract] [Full Text] [Related]

  • 5. Resistance of sheep erythrocytes to immune lysis by treatment of the cells with a human erythrocyte extract: studies on the site of inhibition.
    Hoffmann EM, Cheng WC, Tomeu EJ, Renk CM.
    J Immunol; 1974 Nov; 113(5):1501-9. PubMed ID: 4424275
    [No Abstract] [Full Text] [Related]

  • 6. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ, Ramsey J, Hammer CH, Frank MM.
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [Abstract] [Full Text] [Related]

  • 7. Immunochemical quantitaion of the third component of guinea pig complement in fluid phase and bound to cell surfaces.
    Ohanian SH, Borsos T.
    J Immunol; 1975 Jan; 114(1 Pt 2):326-30. PubMed ID: 1167878
    [Abstract] [Full Text] [Related]

  • 8. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
    Rosenfeld SI, Jenkins DE, Leddy JP.
    J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820
    [Abstract] [Full Text] [Related]

  • 9. Trinitrophenylated red cells (E-TNP) as a model for antibody-independent activation of the complement system via the classical pathway.
    Loos M, Thesen R.
    J Immunol; 1978 Jul; 121(1):24-8. PubMed ID: 670702
    [Abstract] [Full Text] [Related]

  • 10. Activation of the fifth and sixth component of the complement system: similarities between C5b6 and C(56)a with respect to lytic enhancement by cell-bound C3b or A2C, and species preferences of target cell.
    Hänsch GM, Hammer CH, Mayer MM, Shin ML.
    J Immunol; 1981 Sep; 127(3):999-1002. PubMed ID: 6911149
    [Abstract] [Full Text] [Related]

  • 11. Effect of concanavalin A on the classical complement pathway.
    Langone JJ, Boyle MD, Borsos T.
    J Immunol; 1977 May; 118(5):1622-5. PubMed ID: 858916
    [Abstract] [Full Text] [Related]

  • 12. Purification of lipoteichoic acids by using phosphatidyl choline vesicles.
    Silvestri LJ, Craig RA, Ingram LO, Hoffmann EM, Bleiweis AS.
    Infect Immun; 1978 Oct; 22(1):107-18. PubMed ID: 730344
    [Abstract] [Full Text] [Related]

  • 13. Mechanism of complement-induced cell lysis. Demonstration of a three-step mechanism of EAC1-8 cell lysis by C9 and of a non-osmotic swelling of erythrocytes.
    Valet G, Opferkuch W.
    J Immunol; 1975 Oct; 115(4):1028-33. PubMed ID: 809505
    [Abstract] [Full Text] [Related]

  • 14. Protective effects of various compounds on lysis of antibody-coated sheep erythrocytes by hypotonic shock or complement.
    Müller-Peddinghaus R, Erdtmann K.
    Methods Find Exp Clin Pharmacol; 1984 Jun; 6(6):287-92. PubMed ID: 6748820
    [Abstract] [Full Text] [Related]

  • 15. Lytic activity of C5-9 complexes for erythrocytes from the species other than sheep: C9 rather than C8-dependent variation in lytic activity.
    Yamamoto KI.
    J Immunol; 1977 Oct; 119(4):1482-5. PubMed ID: 894048
    [Abstract] [Full Text] [Related]

  • 16. Activation of the alternative complement pathway by pneumococcal lipoteichoic acid.
    Hummell DS, Swift AJ, Tomasz A, Winkelstein JA.
    Infect Immun; 1985 Feb; 47(2):384-7. PubMed ID: 3881346
    [Abstract] [Full Text] [Related]

  • 17. Formation of cross-reacting antibodies against cellular and extracellular lipoteichoic acid of Streptococcus mutans BHT.
    Knox KW, Markham JL, Wicken AJ.
    Infect Immun; 1976 Mar; 13(3):647-52. PubMed ID: 1270127
    [Abstract] [Full Text] [Related]

  • 18. Effect of monoclonal antibodies against lipoteichoic acid from the oral bacterium Streptococcus mutans on its adhesion and plaque-accumulation in vitro.
    Stashenko P, Peros WJ, Gibbons RJ, Dearborn SM.
    Arch Oral Biol; 1986 Mar; 31(7):455-61. PubMed ID: 3467668
    [Abstract] [Full Text] [Related]

  • 19. A new activity of complement component C3: cell-bound C3b potentiates lysis of erythrocytes by C5b,6 and terminal components.
    Hammer CH, Abramovitz AS, Mayer MM.
    J Immunol; 1976 Sep; 117(3):830-4. PubMed ID: 956655
    [Abstract] [Full Text] [Related]

  • 20. Species-restricted target cell lysis by human complement: complement-lysed erythrocytes from heterologous and homologous species differ in their ratio of bound to inserted C9.
    Hu VW, Shin ML.
    J Immunol; 1984 Oct; 133(4):2133-7. PubMed ID: 6470486
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.